Equity Research Analyst - Long-Short

Raj S, CA, CFA

I am Raj - CA and CFA

I cover BFSI, NBFCs, Autos and several other sectors across geographies.
   
I am a CA and CFA with 10+ years experience in fundamental equity research across buy-side and sell-side and across geographies.

My research process is primarily focused on highlighting the catalysts which would have a direct impact on a stocks fundamental performance and market valuation. I try to cut through the noise and sort through the detail, in order to organize and simplify my thinking about an investment thesis.  

Please reach out to us for customized services which can help your office or fund, whether that be shadow coverage of specific companies or a more customized service. We provide a wide range of services at efficient pricing. PM me for a discussion. Thank you for your time.

The Week That Was in ASEAN@Smartkarma - BBNI's Aspirations, Oceanagold IPO, and Thailand's Recovery

Indonesian Banks Screener; Mandiri Is Our Top Pick on Quality and Return Trends

Indonesian Banks Screener; Negara Stands Out on Value, Growth Potential and Improving Return Trends

Bank Mandiri (BMRI IJ) - Setting the Pace in 2024

Bank Mandiri (BMRI IJ) - Raising Our FY24-25F Forecast and TP Post 4Q23 Earnings Beat

BBNI IJ Initiation: On a Rewarding Journey to 20% ROE

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Artoval Advisors

Art’o’val stands for Art of Valuation. Artoval Advisors LLP is a professionally run advisory firm catering to various financial advisory services including Valuation, Investment Research, Training, Accounting, CFO Services and other ancillary services.

We are passionate about what we do and strongly believe in working with our clients as their extended teams. With Artoval Advisors as their trusted partner, our clients find it easy to achieve efficiency in service delivery without compromising on quality.

True Art of Valuation

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/bank-mandiri-persero-tbk-pt" target="_blank" data-smartkarma-citation="entities:441:1" rel="noopener">BMRI</a> is more profitable than <a href="https://www.smartkarma.com/entities/bank-negara-indonesia-persero" target="_blank" data-smartkarma-citation="entities:8285:1" rel="noopener">BBNI</a>, less cyclical than <a href="https://www.smartkarma.com/entities/bank-rakyat-indonesia-persero" target="_blank" data-smartkarma-citation="entities:484:1" rel="noopener">BBRI</a>  and less expensive than <a href="https://www.smartkarma.com/entities/bank-central-asia-tbk-pt" target="_blank" data-smartkarma-citation="entities:440:1" rel="noopener">BBCA</a>. This combination makes it an attractive play on the Indonesia credit growth story.</li>
<li>BMRI's FY23 results are a strong beat with industry-leading loan growth and strong ROE; BMRI also has the potential to aggressively grow its retail portfolio which still is likely under-appreciated</li>
<li>BMRI still trades at a discount to BBRI and has the potential to re-rate by another 20% in the near term, apart from the compounding driven by strong loan growth.</li>
</ul>



BMRI is more profitable than BBNI, less cyclical than BBRI  and less expensive than BBCA. This combination makes it an attractive play on the Indonesia credit growth story.
BMRI's FY23 results are a strong beat with industry-leading loan growth and strong ROE; BMRI also has the potential to aggressively grow its retail portfolio which still is likely under-appreciated
BMRI still trades at a discount to BBRI and has the potential to re-rate by another 20% in the near term, apart from the compounding driven by strong loan growth.


BMRI IJ Initiation: Growth at Reasonable Price!

Bank Mandiri Persero

BMRI IJ Initiation: Growth at Reasonable Price!